In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?

Answer from: Radiation Oncologist at Community Practice

I would treat breast only for most of these patients with favorable early-stage disease. More so with B-51 not showing benefit even in clinical positive becoming negative.

Please select the option that best describes you:

In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?

Related Questions